scispace - formally typeset
J

Jesse V. Jokerst

Researcher at University of California, San Diego

Publications -  176
Citations -  11251

Jesse V. Jokerst is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 40, co-authored 131 publications receiving 8842 citations. Previous affiliations of Jesse V. Jokerst include University of Montana & University of Texas at Austin.

Papers
More filters
Journal ArticleDOI

Nanoparticle PEGylation for imaging and therapy

TL;DR: A background to investigators new to stealth nanoparticles is presented, and some key considerations needed prior to designing a nanoparticle PEGylation protocol and characterizing the performance features of the product are suggested.
Journal ArticleDOI

Semiconducting polymer nanoparticles as photoacoustic molecular imaging probes in living mice

TL;DR: Near infrared (NIR) light absorbing semiconducting polymer nanoparticles (SPNs) are introduced as a new class of contrast agents for PA molecular imaging and demonstrate SPNs an ideal nanoplatform for developing PA molecular probes.
Journal ArticleDOI

A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle

TL;DR: It is shown that a unique triple-modality magnetic resonance imaging–photoacoustic imaging–Raman imaging nanoparticle approach can accurately help delineate the margins of brain tumors in living mice both preoperatively and intraoperatively.
Journal ArticleDOI

Molecular afterglow imaging with bright, biodegradable polymer nanoparticles

TL;DR: S semiconducting polymer nanoparticles <40 nm in diameter are presented that store photon energy via chemical defects and emit long-NIR afterglow luminescence at 780 nm with a half-life of ∼6 min with high-contrast lymph node and tumor imaging in living mice.
Journal ArticleDOI

Molecular Imaging with Theranostic Nanoparticles

TL;DR: Diagnosis imaging and therapeutic uses of NPs are described and examples of five primary types of nanoparticles with concurrent diagnostic and therapeutic use are proposed.